CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: alpha-Zearalanol
Accession: CHEBI:35064
browse the term
Definition: A macrolide that has formula C18H26O5.
Synonyms: related_synonym: Formula=C18H26O5; InChI=1S/C18H26O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h10-12,14,19-21H,2-9H2,1H3/t12-,14+/m0/s1; InChIKey=DWTTZBARDOXEAM-GXTWGEPZSA-N; SMILES=C[C@H]1CCC[C@H](O)CCCCCc2cc(O)cc(O)c2C(=O)O1; Zeranol; ralabol; zearalanol; zearanol
xref: CAS:26538-44-3; Drug_Central:2860; KEGG:C14752; KEGG:D06362
xref_mesh: MESH:D015029
G
Afp
alpha-fetoprotein
affects binding
EXP
Zeranol binds to AFP protein
CTD
PMID:25349334
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
Zeranol inhibits the reaction [Homocysteine results in increased expression of BAX protein]
CTD
PMID:16757814
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions increases expression
ISO
Zeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein] Zeranol results in increased expression of BCL2 protein
CTD
PMID:16757814 PMID:27224899
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
Zeranol results in decreased expression of BCL2L1 protein
CTD
PMID:24120472
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Ccnd1
cyclin D1
increases expression decreases expression
ISO
Zeranol results in increased expression of CCND1 protein Zeranol results in decreased expression of CCND1 protein
CTD
PMID:22113133 PMID:24120472
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Zeranol results in decreased expression of CDK2 protein
CTD
PMID:24120472
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Zeranol results in decreased expression of CDK4 protein
CTD
PMID:24120472
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
ISO
Zeranol results in increased expression of CITED2 mRNA
CTD
PMID:11331657
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Crh
corticotropin releasing hormone
multiple interactions increases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Zeranol results in increased expression of CRH mRNA] Zeranol results in increased expression of CRH mRNA; Zeranol results in increased expression of CRH protein
CTD
PMID:23538034
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Crhr1
corticotropin releasing hormone receptor 1
increases expression
ISO
Zeranol results in increased expression of CRHR1 mRNA
CTD
PMID:24120472
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Edn1
endothelin 1
multiple interactions
ISO
Zeranol inhibits the reaction [Homocysteine affects the expression of EDN1 protein]
CTD
PMID:16757814
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Esr1
estrogen receptor 1
affects binding increases activity
ISO EXP
Zeranol binds to ESR1 protein Zeranol results in increased activity of ESR1 protein
CTD
PMID:11331656 PMID:19913605 PMID:30742918
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
affects binding
EXP ISO
Zeranol binds to ESR2 protein
CTD
PMID:19913605 PMID:30742918
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Gstm5
glutathione S-transferase, mu 5
increases expression
ISO
Zeranol results in increased expression of GSTM3 mRNA
CTD
PMID:11331657
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Ifng
interferon gamma
decreases secretion
ISO
Zeranol results in decreased secretion of IFNG protein
CTD
PMID:14636701
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ins1
insulin 1
multiple interactions
ISO
[Zeranol co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of TRPC6 protein; [Zeranol co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of TRPV1 protein
CTD
PMID:33689779
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Jag1
jagged canonical Notch ligand 1
increases expression
ISO
Zeranol results in increased expression of JAG1 protein
CTD
PMID:22113133
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Maoa
monoamine oxidase A
increases expression
ISO
Zeranol results in increased expression of MAOA mRNA
CTD
PMID:10811566 PMID:11331657
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Mapk1
mitogen activated protein kinase 1
decreases expression increases expression multiple interactions increases phosphorylation
ISO
Zeranol results in decreased expression of MAPK1 protein Zeranol results in increased expression of MAPK1 protein modified form ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Zeranol results in increased phosphorylation of MAPK1 protein]; ML 204 inhibits the reaction [Zeranol results in increased phosphorylation of MAPK1 protein]
CTD
PMID:23538034 PMID:24120472 PMID:27224899
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases expression decreases expression multiple interactions increases phosphorylation
ISO
Zeranol results in increased expression of MAPK3 protein modified form Zeranol results in decreased expression of MAPK3 protein ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Zeranol results in increased phosphorylation of MAPK3 protein]; ML 204 inhibits the reaction [Zeranol results in increased phosphorylation of MAPK3 protein]
CTD
PMID:23538034 PMID:24120472 PMID:27224899
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mir34b
microRNA 34b
decreases expression
ISO
Zeranol results in decreased expression of MIR34B mRNA
CTD
PMID:22113133
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
G
Nos3
nitric oxide synthase 3
multiple interactions
ISO
Zeranol inhibits the reaction [Homocysteine results in decreased expression of NOS3 protein]
CTD
PMID:16757814
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Pgr
progesterone receptor
increases expression
ISO
Zeranol results in increased expression of PGR mRNA
CTD
PMID:24120472
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Pkd2
polycystin 2, transient receptor potential cation channel
increases expression
ISO
Zeranol results in increased expression of PKD2 protein
CTD
PMID:27224899
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
G
Prkcb
protein kinase C, beta
multiple interactions increases phosphorylation
ISO
ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Zeranol results in increased phosphorylation of PRKCB protein]
CTD
PMID:27224899
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prkcd
protein kinase C, delta
increases expression
ISO
Zeranol results in increased expression of PRKCD protein modified form
CTD
PMID:23538034
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression
ISO
ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Zeranol results in increased expression of PTGS2 mRNA]; ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Zeranol results in increased expression of PTGS2 protein]
CTD
PMID:27224899
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptma
prothymosin alpha
decreases expression
EXP
Zeranol results in decreased expression of PTMA protein alternative form
CTD
PMID:10606005
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
G
Rln1
relaxin 1
increases expression
ISO
Zeranol results in increased expression of RLN1 mRNA
CTD
PMID:24120472
NCBI chr 1:227,079,960...227,082,960
Ensembl chr 1:227,079,966...227,082,882
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
ISO
Zeranol results in increased expression of SERPINA3 mRNA
CTD
PMID:10811566
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Shbg
sex hormone binding globulin
affects binding
ISO
Zeranol binds to SHBG protein
CTD
PMID:25349334
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Slc6a14
solute carrier family 6 member 14
increases expression
ISO
Zeranol results in increased expression of SLC6A14 mRNA
CTD
PMID:11331657
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Tff1
trefoil factor 1
increases expression
ISO
Zeranol results in increased expression of TFF1 mRNA
CTD
PMID:10811566 PMID:11331657
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tgfb3
transforming growth factor, beta 3
increases expression
ISO
Zeranol results in increased expression of TGFB3 mRNA
CTD
PMID:10811566 PMID:11331657
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Trpc3
transient receptor potential cation channel, subfamily C, member 3
increases expression
ISO
Zeranol results in increased expression of TRPC3 protein
CTD
PMID:27224899
NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
increases expression multiple interactions
ISO
Zeranol results in increased expression of TRPC6 protein [Zeranol co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of TRPC6 protein
CTD
PMID:27224899 PMID:33689779
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
multiple interactions
ISO
[Zeranol co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of TRPV1 protein
CTD
PMID:33689779
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all